Phase I clinical trial of a TGF-β antisense-modified tumor cell vaccine in patients with advanced glioma

200698 citationsJournal Article

Authors

Good health and well-being

Published in: Cancer Gene Therapy

Volume 13, Issue 12, pp. 1052-1060

Field-Weighted Citation Impact: 3.03